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Abstract. 
 
Maturation of the 
 
Saccharomyces cerevisiae
 
 
 
a
 
-factor precursor involves COOH-terminal CAAX 
processing (prenylation, AAX tripeptide proteolysis, 
and carboxyl methylation) followed by cleavage of an 
NH
 
2
 
-terminal extension (two sequential proteolytic 
processing steps). The aim of this study is to clarify the 
precise role of Ste24p, a membrane-spanning zinc met-
alloprotease, in the proteolytic processing of the 
 
a
 
-fac-
tor precursor. We demonstrated previously that Ste24p 
is necessary for the first NH
 
2
 
-terminal processing step 
by analysis of radiolabeled 
 
a
 
-factor intermediates in 
vivo
 
 
 
(Fujimura-Kamada, K., F.J. Nouvet, and S. 
Michaelis. 1997. 
 
J
 
.
 
 Cell Biol
 
. 136:271–285). In contrast, 
using an in vitro protease assay, others showed that 
Ste24p (Afc1p) and another gene product, Rce1p, 
share partial overlapping function as COOH-terminal 
CAAX proteases (Boyartchuk, V.L., M.N. Ashby, and 
J. Rine. 1997. 
 
Science. 
 
275:1796–1800). Here we resolve 
these apparently conflicting results and provide com-
pelling in vivo evidence that Ste24p indeed functions at 
two steps of 
 
a
 
-factor maturation using two methods. 
First, direct analysis of 
 
a
 
-factor biosynthetic intermedi-
ates in the double mutant (
 
ste24
 
D 
 
rce1
 
D
 
) reveals a pre-
viously undetected species (P0*) that fails to be COOH 
terminally processed, consistent with redundant roles 
for Ste24p and Rce1p in COOH-terminal CAAX pro-
cessing. Whereas 
 
a
 
-factor maturation appears relatively 
normal in the 
 
rce1
 
D
 
 single mutant, the 
 
ste24
 
D
 
 single 
mutant accumulates an intermediate that is correctly 
COOH terminally processed but is defective in cleav-
age of the NH
 
2
 
-terminal extension, demonstrating that 
Ste24p is also involved in NH2-terminal processing. To-
gether, these data indicate dual roles for Ste24p and a 
single role for Rce1p in 
 
a
 
-factor processing. Second, by 
using
 
 
 
a novel set of ubiquitin–
 
a
 
-factor fusions to sepa-
rate the NH
 
2
 
- and COOH-terminal processing events 
of 
 
a
 
-factor maturation, we provide independent evi-
dence for the dual roles of Ste24p.
 
 
 
We also report here 
the isolation of the human (Hs) Ste24p homologue, 
representing the first human CAAX protease to be 
cloned. We show that Hs Ste24p complements the mat-
ing defect of the yeast double mutant (
 
ste24
 
D
 
 
 
rce1
 
D
 
) 
strain, implying
 
 
 
that like yeast Ste24p, Hs Ste24p can 
mediate multiple types of proteolytic events.
Key words: CAAX processing • posttranslational 
modification • metalloproteinases • prenylated protein 
precursor • yeast mating pheromone
 
M
 
any
 
 proteins are synthesized as precursors that
undergo one or more maturation steps to attain
their full activity, to acquire proper localization,
or to facilitate protein–membrane or protein–protein in-
teractions. The 
 
Saccharomyces cerevisiae
 
 mating phero-
 
mone 
 
a-
 
factor provides an excellent model for dissecting
several distinct types of posttranslational modification
events. Fully mature 
 
a-
 
factor (M)
 
1
 
 is a prenylated, car-
boxyl-methylated dodecamer that is initially synthesized
as a precursor encoded by the functionally redundant
genes, 
 
MFA1
 
 and 
 
MFA2
 
. The 
 
a
 
-factor precursor (P0) con-
sists of the mature 
 
a
 
-factor (12 residues) flanked by an
NH
 
2
 
-terminal extension (21 residues for Mfa1p) and a
COOH-terminal CAAX motif (C, cys; A, an aliphatic res-
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1. 
 
Abbreviations used in this paper
 
: E, extracellular; EST, expressed se-
quence tag; Hs, 
 
Homo sapiens
 
; I, intracellular; M, mature; ORF, open
reading frame; Sc, 
 
Saccharomyces cerevisiae
 
; SD, synthetic minimal me-
dium; Sp, 
 
Schizosaccharomyces pombe
 
; Ubi, ubiquitin; Ubp, ubiquitin-
specific protease; YPD, yeast extract/peptone/dextrose medium.
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idue; X, one of several residues) (Michaelis and Herskow-
itz, 1988). A goal of our laboratory is to define the biosyn-
thetic intermediates and cellular components necessary
for each step of 
 
a
 
-factor biogenesis. Our current view of
 
a
 
-factor maturation, derived from pulse-chase and SDS-
PAGE analysis of 
 
a
 
-factor biosynthetic intermediates, is
summarized in Fig. 1. Our studies have shown that 
 
a
 
-factor
biogenesis occurs in three ordered stages: (
 
a
 
) COOH-ter-
minal CAAX processing, (
 
b
 
) NH
 
2
 
-terminal proteolysis
comprised of a pair of successive cleavage events, and (
 
c
 
)
export (Chen et al., 1997
 
b
 
).
In addition to 
 
a
 
-factor, the COOH-terminal CAAX mo-
tif is present on a number of eukaryotic proteins. Exam-
ples include nuclear lamins of multicellular organisms, the
 
g 
 
subunit of a heterotrimeric G protein, and most notably
Ras proteins and the Ras-related Rho proteins (for re-
views see Clarke, 1992; Schafer and Rine, 1992; Zhang and
Casey, 1996). The CAAX motif directs three sequential
posttranslational modification steps: (
 
a
 
) prenylation of the
cysteine by farnesyl or geranylgeranyl, (
 
b
 
) proteolytic
cleavage to remove the AAX residues (herein referred to
as AAXing), and (
 
c
 
) carboxyl methylation of the newly ex-
posed prenyl cysteine (Clarke, 1992; Schafer and Rine,
1992; Zhang and Casey, 1996). The CAAX modifications
confer distinctive properties to the processed protein. For
Ras, the prenyl group is required for its activity and more
importantly, for its transforming activity (Casey et al.,
1989; Schafer et al., 1989; Kato et al., 1992). Likewise for
 
a
 
-factor, the farnesyl group facilitates membrane associa-
tion before export and is necessary for promoting growth
arrest and mating activity by extracellular 
 
a
 
-factor. Re-
moval of the AAX tripeptide is required for methylation,
and in turn, methylation of 
 
a
 
-factor is important for its in-
tracellular stability, export, and receptor interaction
 
 
 
(He
et al., 1991; Marcus et al., 1991; Sapperstein et al., 1994).
In 
 
S
 
.
 
 cerevisiae, 
 
the genetic analysis of mutants defective
in 
 
a-
 
factor biogenesis has facilitated the identification and
characterization of the yeast CAAX processing compo-
nents. These enzymes include (
 
a
 
) the farnesyl transferase
complex (Ram1p/Ram2p); (
 
b
 
) the CAAX prenyl pro-
teases that carry out AAXing (Rce1p or Ste24p [see be-
low]); and (
 
c
 
) the carboxyl methyltransferase (Ste14p)
(Hrycyna and Clarke, 1990; Schafer et al., 1990; He et al.,
1991; Boyartchuk et al., 1997). The genes encoding mam-
malian CAAX processing enzymes that have been cloned
to date are the rat, bovine, and human farnesyltrans-
ferases; the rat and human geranylgeranyltransferase; and
the human prenyl protein carboxylmethyltransferase
(Kohl et al., 1991; Andres et al., 1993; Zhang, 1994 [no.
1610]; Dai et al., 1998). In contrast, no mammalian CAAX
protease genes have as yet been identified.
For 
 
a
 
-factor, COOH-terminal CAAX processing is only
the first stage of its maturation. CAAX processing of the
 
a
 
-factor precursor (P0) produces an intermediate (P1) that
is completely modified at the COOH terminus (farnesy-
lated, AAXed, and carboxyl methylated) but contains an
intact NH
 
2
 
-terminal extension (see Fig. 1). The NH
 
2
 
-ter-
minal extension is removed in two sequential and obliga-
torily ordered NH
 
2
 
-terminal proteolytic cleavages, the first
one yielding the partially processed precursor (P2), and
the second cleavage generating fully mature 
 
a
 
-factor (M).
We recently showed that Ste24p is required for the first
NH
 
2
 
-terminal proteolytic step (P1
 
®
 
P2 processing) (Fu-
jimura-Kamada et al., 1997), as discussed below. The sec-
ond step (P2
 
®
 
M) is mediated by Axl1p and can also be
carried out redundantly by Ste23p (Adames et al., 1995).
Upon completion of the NH
 
2
 
-terminal processing steps,
mature 
 
a
 
-factor is exported from the cell via the Ste6p
transporter, a member of the ATP-binding cassette super-
family (Kuchler et al., 1989; McGrath and Varshavsky,
1989; Michaelis, 1993).
The aim of this study is to clarify the role of Ste24p, a
predicted multiple membrane-spanning zinc metallopro-
tease, in the biogenesis of 
 
a
 
-factor. Interestingly, the
 
STE24
 
 gene was identified by two independent genetic
screens that assigned different functions for Ste24p in
 
a
 
-factor maturation (Boyartchuk et al., 1997; Fujimura-
Kamada et al., 1997). Our laboratory isolated 
 
STE24 
 
as a
mating-defective mutant (hence the designation 
 
ste
 
) in a
screen specifically aimed at identifying mutants with re-
duced mating efficiency (Fujimura-Kamada et al., 1997).
A 
 
ste24 
 
mutant accumulates the 
 
a
 
-factor intermediate P1
in vivo. Since P1 is fully COOH terminally modified but its
NH
 
2
 
-terminal extension is not proteolytically removed in
the 
 
ste24
 
 mutant, we concluded that Ste24p is required for
the first NH
 
2
 
-terminal processing step (P1
 
®
 
P2) of 
 
a
 
-factor
maturation. In a separate screen using a mutant version of
 
a
 
-factor with an altered CAAX motif (CAMQ instead of
CVIA), Boyartchuk et al. (1997) also identified 
 
STE24
 
(called 
 
AFC1 
 
in their study, 
 
a
 
-factor converting enzyme).
Using an in vitro assay for release of the AAX tripeptide,
 
ste24
 
 mutants showed reduced AAXing activity. Bo-
yartchuk et al.
 
 
 
(1997)
 
 
 
concluded that Ste24p and a second
functionally redundant protein, Rce1p, share overlapping
roles in the COOH-terminal AAXing step of 
 
a
 
-factor mat-
uration. Rce1p, which is predicted to contain multiple
membrane spans, bears no sequence similarity to Ste24p,
and lacks any known protease motifs. Although 
 
STE24
 
was identified in genetic screens based on defective extra-
cellular 
 
a
 
-factor production, the two reports reached sur-
prisingly different conclusions regarding the role of Ste24p
in 
 
a
 
-factor maturation. Likely explanations for the diver-
gent findings are that Boyartchuk et al. (1997) examined
only COOH-terminal processing in their in vitro AAXing
assay and our study did not detect an AAXing defect in
vivo for the single 
 
ste24
 
 mutant because AAXing can be
carried out redundantly by Rce1p.
In this study, we reconcile the apparently conflicting
data for the roles of Ste24p in 
 
a
 
-factor processing. We ex-
amine both NH
 
2
 
- and COOH-terminal processing of 
 
a
 
-fac-
tor in vivo in strains deleted for 
 
STE24
 
 and RCE1. By di-
rectly analyzing the a-factor biosynthetic intermediates
produced by the mutant strains, we provide evidence that
Ste24p indeed participates in both NH2- and COOH-ter-
minal processing steps. In contrast, Rce1p is involved only
in CAAX processing, not NH2-terminal cleavage of a-fac-
tor. We also use an independent method employing
ubiquitin (Ubi)–a-factor fusions that uncouple the NH2-
and COOH-terminal processing steps to demonstrate the
dual roles for Ste24p in a-factor maturation. Finally, we re-
port here the cloning of the human Ste24p homologue, the
first mammalian CAAX prenyl protease. We show that Hs
Ste24p can complement the yeast double deletion (ste24
rce1) strain for mating.Tam et al. Dual Roles for Ste24p in Yeast a-Factor Maturation 637
Materials and Methods
Strains and Media
The yeast strains used in this study are listed in Table I. The rce1-D1::
TRP1 deletion allele, referred to as rce1D, replaces codons 116 to the stop
codon 315 with TRP1. Strains (SM3613, SM3614, SM3689, and SM3691)
harboring the rce1D allele were constructed using one-step gene disrup-
tion by transforming SM1058, SM3103, SM2331, and SM3375, respec-
tively, with a BamHI-XhoI fragment from pSM1285 bearing rce1-D1::
TRP1, and selecting for Trp1 transformants. The ste24D::LEU2 deletion
allele, referred to as ste24D, is a g disruption of ste24 that eliminates nearly
the entire coding sequence (codons 1–444 of 453 total). Strains (SM3375
and others) harboring this allele were constructed by transformation of
SM2331 with linearized pSM1072 and selection of Leu1 transformants, as
described (Fujimura-Kamada et al., 1997). All deletion strains were con-
firmed by Southern analysis. MATa strains bearing the single (rce1D) and
the double (ste24D rce1D) deletions were constructed by mating-type
switching of MATa strains SM3613 and SM3614, respectively, using the
HO endonuclease as described (Herskowitz and Jensen, 1991). Yeast
transformations were performed by the Elble method (Elble, 1992). All
strains were grown at 308C in complete yeast extract/peptone/dextrose
(YPD) media, synthetic complete drop-out (SC-URA, TRP, LEU), or
synthetic minimal media (SD) (Michaelis and Herskowitz, 1988; Kaiser et al.,
1994).
Patch Mating Test and a-Halo Assay
To assay mating, we used the semiquantitative patch mating test as de-
scribed previously (Fujimura-Kamada et al., 1997). In this assay, master
plates containing patches of strains to be tested are replica plated onto a
mating tester lawn of the opposite mating type that has been spread on an
SD plate. The lawn is prepared by resuspending the mating tester strain in
YPD and spreading 0.3 ml of this suspension onto an SD plate. The strin-
gency for the patch mating test was increased by resuspending the mating
tester lawns in decreasing concentrations of YPD diluted in sterile water
(100% YPD is permissive, 1% YPD is stringent) since limiting nutrients
decrease plate mating efficiency, and thereby increase the mating test sen-
sitivity. The strains tested are Trp2, Leu2, or His2 auxotrophs, whereas
the mating testers (SM1067 and SM1068) are Lys2. Only cells that mate to
generate prototrophic diploids are able to grow on SD minimal media af-
ter incubation for 2 d at 308C.
To compare the level of extracellular a-factor for wild-type and mutant
strains, we performed the a-factor spot halo assay as described previously
(Nijbroek and Michaelis, 1998). Serial dilutions of concentrated a-factor
(2  ml) were spotted onto a lawn of supersensitive halo tester cells
(SM1086) spread on a YPD plate. Plates were incubated for 1 d at 308C.
Plasmid Constructions
The plasmids used in this study are listed in Table II. The single-step gene
disruption plasmid, pSM1285, used to generate rce1-D1::TRP1 alleles, was
constructed as follows: A HindIII-MluI fragment containing the RCE1
open reading frame (ORF) from pHY01 (provided by A. Toh-e, Univer-
sity of Tokyo, Tokyo, Japan) (Yashiroda et al., 1996) was rendered blunt-
ended with Klenow and subcloned into the EcoRV-SmaI sites of pBlue-
scriptIISK (Stratagene, La Jolla, CA) to yield pSM1284. Plasmid
pSM1284 was digested with EcoRI to remove a fragment corresponding
to the last 200 codons of the RCE1 ORF, which was replaced with a TRP1
EcoRI fragment from pUC18-TRP1 (Sapperstein et al., 1994) to generate
pSM1285.
Ubi–a-factor fusion constructs encode chimeric proteins consisting of
ubiquitin (76 residues) fused either to the full-length a-factor precursor
encoded by MFA1, to the NH2 terminally truncated a-factor (P2) (see Fig.
1), or to mature a-factor (M). All of these fusions contain the intact
COOH-terminal CAAX motif and are expressed under the control of the
MFA1 promoter. These constructs are designated Ubi-P1, Ubi-P2, and
Ubi-M, where the a-factor segments correspond to codons 1–36 (full-
length), codons 8–36, and codons 21–36 of MFA1-encoded a-factor, re-
spectively. The fusion constructs were generated by recombination-medi-
ated PCR cloning, a method in which a linearized or gapped acceptor
plasmid serves as the target for homologous recombination directed by a
donor PCR fragment in yeast (Muhlrad et al., 1992; Oldenburg et al.,
1997). The PCR fragments were amplified with oligonucleotides encoding
precise fusion junctions between the COOH terminus of ubiquitin and the
NH2 terminus of the various species of a-factor.
The linear target vector and the donor PCR fragment were cotrans-
formed into a strain deleted for the chromosomal a-factor genes mfa1D
and mfa2D (SM2331). Subsequently, candidate plasmids were screened by
yeast colony PCR. In brief, crude yeast extracts were prepared by incubat-
ing a small amount of yeast cells in 60 ml of lysis buffer (0.45% NP-40,
0.45% Tween 20, 50 mM KCl, 10 mM Tris, pH 8.3, 1.5 mM MgCl2, 0.1%
gelatin, 0.3 mg/ml zymolyase) for 90 min at 378C. The cleared lysate (5 ml)
was used as the template for the PCR screening. Plasmids were recovered
from yeast as described (Robzyk and Kassir, 1992). Ubi-P1, Ubi-P2, and
Ubi-M are encoded by pSM1368, pSM1369, and pSM1366, respectively.
All Ubi-a-factor fusion plasmids were amplified in Escherichia coli strain
DH5a, prepared by alkaline lysis, analyzed by restriction digests, and then
confirmed by DNA sequencing.
Metabolic Labeling, Immunoprecipitation,
and SDS-PAGE
To examine a-factor biosynthetic intermediates, extracts were prepared
from metabolically labeled cells and radiolabeled proteins were immuno-
precipitated with anti–a-factor antiserum and analyzed by SDS-PAGE, es-
sentially as previously described (Chen et al., 1997b; Fujimura-Kamada et al.,
1997). In brief, 5 OD600 U log phase cells were harvested and resuspended
in 250 ml of SD media supplemented with the appropriate amino acids.
Cells were pulse labeled with 150 mCi [35S]cysteine for the indicated times,
and the labeling was stopped on ice by the addition of an equal volume of
23 azide buffer (40 mM methionine, 40 mM cysteine, 20 mM NaN3, 500
mg/ml BSA). For pulse-chase experiments, chases were initiated by addi-
tion of 10 ml of 1 M cysteine per time point. Intracellular (I) and extracel-
lular (E) fractions were processed as described (Chen et al., 1997b;
Fujimura-Kamada, et al., 1997). Radiolabeled a-factor was immunopre-
cipitated with anti–a-factor antiserum 9-137 or 9-497, and the immunopre-
cipitated material was subjected to SDS-PAGE and PhosphorImager
(Molecular Dynamics, Inc., Sunnyvale, CA) analysis as described (Chen
et al., 1997b). To maximize the resolution between partially processed
a-factor precursors, we used 16% polyacrylamide separating gels that
were 13 cm in length. The half-life of each a-factor precursor (P0* or P1)
was determined by quantitation of the [35S] counts corresponding to the
a-factor signal using ImageQuant software (Molecular Dynamics, Inc.).
The 0 min time point was used as the 100% reference value for each time
course experiment.
a-Factor Carboxyl Methylation Assay
The carboxyl methylation levels of the immunoprecipitated a-factor inter-
mediates that had been cut out of a dried polyacrylamide gel were mea-
sured (Fujimura-Kamada et al., 1997). In general, the procedure involves
generating double-labeled a-factor with [3H] at the carboxyl methyl group
and with [35S] at the prenyl cysteine. For each a-factor species (P0*, P1,
P2, or M), the ratio of [3H]/[35S] cpm reflects the absolute methylation
level. The relative methylation level is then determined by dividing the
absolute methylation level of the mutant strain by that of the wild-type
strain and converting this number to a percentage value.
Specifically, this procedure was carried out in two steps. First, cells
were radiolabeled, immunoprecipitated, and subjected to SDS-PAGE, as
described in the previous section, with the following changes: cells were
double-labeled with 50 mCi S-adenosyl-l-[3H-methyl]methionine and 150
mCi [35S]cysteine for 6 min. For this assay, labeled cells were not lysed by
base treatment since base hydrolysis could release the methyl esters which
we wish to detect in this assay (see below). Instead, protein extracts were
prepared by vortexing labeled cells at 48C with zirconium beads in break-
ing buffer (50 mM potassium phosphate buffer, pH 7.4, 150 mM NaCl, 1%
Triton X-100, 1% sodium deoxycholate, 1 mM 2-mercaptoethanol, 1 mM
PMSF). After separation by SDS-PAGE, the radiolabeled and immuno-
precipitated a-factor intermediates were visualized by autoradiography.
Second, to determine the extent of carboxyl methylation for each a-fac-
tor intermediate, we measured the levels of [3H] and of [35S] incorporation
by scintillation counting. The a-factor gel bands were excised from dried
gels. The [3H] labeling was determined by the vapor-phase diffusion assay,
which detects volatile [3H]methyl esters (i.e., carboxyl methyl) cleaved by
base hydrolysis (Xie et al., 1990; Hrycyna et al., 1991). Gel slices (P0*, P1,
P2, and M) were placed in an open microfuge tube containing 150 ml of 1 M
NaOH. The microfuge tube was placed inside a tightly capped 20 ml scin-
tillation vial that contained 5 ml of scintillation fluid such that the contentsThe Journal of Cell Biology, Volume 142, 1998 638
of the microfuge tube did not mix with the scintillation fluid. After incuba-
tion at 378C for 24–36 h, the released volatile [3H]methanol was measured
by scintillation counting. The total amount of [35S] incorporated into each
a-factor species was then determined. First, the contents of the microfuge
tube (including the gel slice) were neutralized with 100 ml of glacial acetic
acid and then dissolved in 1 ml of Solvable (New England Nuclear Re-
search Products, Boston, MA), a tissue solubilizer, in capped microfuge
tubes at 658C for 6 h. The [35S] counts of the entire sample were then mea-
sured by liquid scintillation counting. The ratio of [3H] cpm to [35S] cpm
was calculated for each a-factor species to give the absolute methylation
level. The relative methylation level was determined by dividing the abso-
lute methylation level of the mutant strain by the absolute methylation
level of the corresponding wild-type a-factor species.
Human STE24 Cloning
A BLAST search (Altschul et al., 1990) of the database of expressed
sequence tags (ESTs) revealed several human ESTs with high amino acid
similarity to S. cerevisiae (Sc) Ste24p. These ESTs represented cDNAs
from many cell types. A 703-bp HindIII fragment from EST N76181
National Center for Biotechnology Information (NCBI) (no. 69928) was
used to screen z3 3 106 clones from a human B cell cDNA library (pro-
vided by S. Elledge, Baylor College of Medicine, Houston, TX) by stan-
dard methods (Ausubel, 1987). Nine positive clones were obtained and
sequenced, each of which encoded partial ORFs corresponding to the 39
end of human STE24. The most complete Homo sapiens (Hs) clone
contained an ORF encoding 383 residues and included the poly A tail. To
obtain the remaining 59 Hs STE24 ORF, this clone was used in 59 rapid
amplification of cDNA ends (RACE) PCR procedure with a fetal brain
library according to the Marathon-Ready cDNA kit (Clontech, Palo Alto,
CA). The full-length STE24 ORF was subcloned by recombination-medi-
ated PCR cloning into a yeast plasmid such that the coding sequence of Sc
STE24 was precisely replaced with that of Hs STE24. The resulting plas-
mid (pSM1468) contains the 59 upstream and 39 downstream sequences of
the yeast STE24 ORF flanking the human STE24 ORF.
Results
Mating Phenotype and Extracellular a-Factor 
Production by ste24D, rce1D, and ste24D rce1D Mutants
To examine the roles of Ste24p and Rce1p in a-factor mat-
uration, we first compared the extracellular a-factor pro-
duced from strains deleted for STE24 and RCE1. We used
the spot halo dilution assay, which provides a semiquanti-
tative measure of the amount of mature a-factor secreted
by these strains. In this assay, extracellular a-factor causes
the growth arrest of a lawn of supersensitive MATa sst2
cells, resulting in a clear zone (Michaelis and Herskowitz,
1988; Nijbroek and Michaelis, 1998). The relative amounts
of a-factor produced by the different strains are compared
by determining the highest dilution that yields a clear spot
(Fig. 2 A). Whereas the ste24D mutant produces signifi-
cantly decreased levels of extracellular a-factor (eightfold
less than wild-type), the rce1D mutant is virtually indistin-
guishable from wild-type (Fig. 2 A). In contrast, we detect
no extracellular a-factor for the double ste24D rce1D mu-
tant. This result is consistent with the notion that Ste24p
and Rce1p play redundant roles in the COOH-terminal
AAXing step of a-factor maturation, such that only one
gene must be intact for AAXing to occur, as proposed by
Boyartchuk et al. (1997). However, the more severe phe-
notype of the ste24D single mutant versus the rce1D single
mutant most likely reflects the additional role of Ste24p in
the NH2-terminal processing of a-factor.
A comparison of the MATa strains in a plate mating as-
say indicates that their mating efficiencies parallel the re-
sults of the a-factor spot dilution assay. As shown in Fig. 2
B, the rce1D mutant mates like wild-type as indicated by
the confluent growth of diploids, whereas the ste24D mu-
tant has a leaky mating defect as indicated by growth of
fewer diploids. The double mutant fails to mate alto-
gether, consistent with its complete lack of extracellular
a-factor production (Fig. 2 B). Importantly, the mating
defects exhibited by these mutants is MATa cell type-spe-
Figure 1. Pathway of a-factor biogenesis. The a-factor precursor,
biosynthetic intermediates, and components of the biogenesis
machinery are shown. The biogenesis of a-factor is comprised of
three stages, indicated at left: (a) COOH-terminal CAAX pro-
cessing, (b) two sequential NH2-terminal proteolytic cleavages,
and (c) export. The a-factor precursor (P0, top) consists of the
mature, bioactive portion (black) flanked by an NH2-terminal ex-
tension (two shades of gray) and a COOH-terminal CAAX motif.
Mature a-factor is a prenylated and carboxyl methylated dode-
capeptide (M, bottom). The known a-factor biosynthetic interme-
diates that can be directly visualized by SDS-PAGE are desig-
nated P0, P1, P2, and M (Chen et al., 1997b). In this study, we
present the previously undetected intermediate P0*. The cellular
components that mediate COOH-terminal CAAX modification
events (prenylation, AAX proteolysis, carboxyl methylation) are
the Ram1p/Ram2p complex, Rce1p and Ste24p, and Ste14p, re-
spectively (refer to text for more details). NH2-terminal process-
ing involves two successive proteolytic steps. The first NH2-termi-
nal cleavage step (P1®P2) is mediated by Ste24p (as confirmed
by this study), and the second step (P2®M) requires Axl1p or
Ste23p. The dual roles of Ste24p in COOH-terminal AAXing and
the first NH2-terminal (P1®P2) processing step is the subject of
this study.Tam et al. Dual Roles for Ste24p in Yeast a-Factor Maturation 639
cific, since MATa strains bearing either the single (ste24D)
or double (ste24D rce1D) mutations did not have any mat-
ing defects (Fig. 2 B). Because MATa and MATa cells dif-
fer mainly by pheromone and receptor expression, the
MATa mating defects seen in the ste24D and ste24D rce1D
mutants are likely to reflect specific effects on a-factor bio-
genesis.
A Novel a-Factor Intermediate (P0*) Is Observed in the 
Double ste24D rce1D Mutant
To directly examine the roles of STE24 and RCE1 in a-fac-
tor maturation, we compared the a-factor biosynthetic in-
termediates produced in strains deleted for STE24 and
RCE1. Cells were metabolically labeled, and the a-factor
biosynthetic intermediates were immunoprecipitated and
separated by SDS-PAGE. For the wild-type strain, the
typical profile of the intracellular (I) forms of a-factor in-
cludes the partially processed precursor species (P1 and
P2) and mature (M) a-factor (Fig. 3 A, lane 1; refer to Fig.
1 for a description of each band). The band migrating
slightly faster than M is the a-factor–related peptide
(AFRP), whose biogenesis involves mechanisms and ma-
chinery distinct from those used to generate mature a-fac-
tor (Chen et al., 1997a). The extracellular (E) fraction con-
tains exported mature (M) a-factor (Fig. 3 A, lane 1). For
the rce1D  mutant, the biosynthetic profile is similar to
wild-type (Fig. 3 A, lane 2). Because the stepwise removal
of the NH2-terminal extension appears to be normal in
the rce1D mutant, Rce1p does not play a major role in
NH2-terminal processing of a-factor. Furthermore, this ap-
parently normal processing in the rce1D mutant is ex-
pected if Ste24p and Rce1p play redundant functions in
COOH-terminal AAXing of a-factor (see below), since
Ste24p would compensate for the lack of Rce1p. In con-
trast, the ste24D mutant has a dramatic phenotype of P1
accumulation (Fig. 3 A, lane 3), as we have also shown pre-
viously (Fujimura-Kamada et al., 1997). In the ste24D mu-
tant, COOH-terminal AAXing is complete but the cleav-
age of the NH2-terminal extension is defective, indicating
that Ste24p is necessary for the first NH2-terminal cleav-
age step (P1®P2) in a-factor maturation (see also Fig. 3
B). Notably, only a tiny amount of mature a-factor pro-
duced by the ste24D mutant is detected in the extracellular
fraction by SDS-PAGE and autoradiography after a long
exposure (Fujimura-Kamada et al., 1997); the more sensi-
tive spot halo assay detects this low level of extracellular
mature a-factor (refer to Fig. 2 A).
If Ste24p does indeed function redundantly in COOH-
terminal AAXing with Rce1p, then we predict that the
double mutant (ste24D rce1D) would be completely defec-
tive for a-factor AAXing. Such a processing block should
produce a new intermediate (P0*) that is prenylated but
retains its AAX and thus cannot be methylated (refer to
Fig. 1). In the double mutant (ste24D rce1D), we observe a
single band, designated P0*, that shows a subtle mobility
shift compared with P1 (Fig. 3 A, compare lane 4 with 3).
Since this slight mobility difference is difficult to detect
consistently, we used a methylation assay, described be-
low, to show that the intermediate generated by the dou-
ble mutant is truly distinct from P1.
Methylation can serve as an indirect AAXing assay,
since AAXing is required to expose the methylation sub-
strate, the free carboxyl of prenyl cysteine (Hrycyna and
Clarke, 1992; Ashby and Rine, 1995; Hrycyna et al., 1995).
We measured the degree of carboxyl methylation for each
intracellular a-factor species made in wild-type and mu-
tant strains. Cells were metabolically double-labeled
with S-adenosyl-l-[3H-methyl]methionine and [35S]cysteine,
which label the COOH-methyl and prenyl cysteine of
a-factor, respectively. Methylation levels were first normal-
ized to protein levels ([3H]/[35S]) and then calculated as a
fraction of the corresponding a-factor intermediate from
the wild-type strain (refer to Materials and Methods). As
we have previously shown, the P1 intermediate produced by
the ste24D mutant is completely methylated relative to the
methylation levels of the wild-type strain (Fig. 3 B)
(Fujimura-Kamada et al., 1997), indicating that this strain
has AAXing activity, presumably mediated by Rce1p. In
the rce1D mutant, we also detect a significant amount of
methylation of P2 and M, although the levels are somewhat
reduced, and the slowest migrating species (Fig. 3 B, top
band) is not detectably methylated (see below). The methy-
lation that occurs in the rce1D mutant most likely reflects
the AAXing activity mediated by Ste24p. In contrast to the
single mutants, the double ste24D rce1D mutant produces a
single intermediate that is completely unmethylated (Fig.
Figure 2. STE24 and RCE1
are required for the efficient
production of a-factor by
MATa cells. (A) a-Factor spot
dilution assay. The a-factor–
induced growth arrest of a
MATa supersensitive (sst2)
tester lawn results in a clear
zone or spot. Dilutions of con-
centrated, extracellular a-fac-
tor produced by a wild-type
strain, the single (rce1D and
ste24D) and double (ste24D
rce1D)  mutants were prepared
as described in the Materials
and Methods and spotted onto
a lawn of the MATa halo
tester (SM1086) on YPD. The
highest dilution yielding a
clear spot is the titer of a-fac-
tor for that strain. The papil-
lae arising in the clear spots
are revertants arising from the sst2 lawn (Chan and Otte, 1982).
(B) Patch mating assay. Strains bearing the single and double
rce1D ste24D mutations were tested for the ability to mate with
cells of the opposite mating type. Patches of the MATa or MATa
strains to be tested for mating were replica-plated from a patch
master plate onto a lawn of auxotrophic mating tester cells spread
on minimal SD media. The growth of prototrophic diploids is in-
dicative of mating. MATa strains do not exhibit mating defects
even under stringent mating conditions (5% YPD) (data not
shown). MATa strains tested are wild-type (SM1058), rce1D
(SM3613), ste24D (SM3103), and rce1D ste24D (SM3614); the
isogenic MATa strains tested are wild-type (SM1059), rce1D
(SM3811), ste24D (SM3102), and rce1D ste24D (SM3812). The
mating tester lawns are MATa (SM1068) and MATa (SM1067)
and were resuspended in 5% YPD and 50% YPD, respectively,
as described in the Materials and Methods.The Journal of Cell Biology, Volume 142, 1998 640
3 B), and thus represents P0*, a prenylated but unAAXed
biosynthetic intermediate of a-factor. We previously have
not detected P0* probably because it is converted to P1
very quickly. Unexpectedly, the rce1D mutant produces a
precursor species (Fig. 3 A, lane 2, top band) that is likely
to be P0* because it is unmethylated (Fig. 3 B). In this
case, and in contrast to P0* of the double ste24D rce1D mu-
tant, P0* in the rce1D mutant is converted to P2 and then
to M. A likely explanation is that when Ste24p recognizes
P0* in the rce1D mutant, the dual roles of Ste24p permit it
to cleave P0* at both the NH2 and COOH termini to gen-
erate a P2-like intermediate that is subsequently methy-
lated. Our conclusions from this analysis of a-factor inter-
mediates generated in vivo are consistent with AAXing
roles for both Ste24p and Rce1p, and an additional NH2-
terminal processing role for Ste24p only.
Table I. S. cerevisiae Strains Used in This Study
Strain Relevant genotype* Reference
SM1058 MATa trp1 leu2 ura3 his4 can1 Michaelis and Herskowitz, 1988
SM1059 MATa trp1 leu2 ura3 his4 can1 Michaelis and Herskowitz, 1988
SM1067 MATa cry1 lys1 Michaelis and Herskowitz, 1988
SM1068 MATa lys1 Michaelis and Herskowitz, 1988
SM1086 MATa sst2-1 his6 met1 can1 cyh2 Michaelis and Herskowitz, 1988
SM1871 MATa ste14:: TRP1 [CEN URA3 MFA1] Sapperstein et al., 1994
SM2331 MATa mfa1-D1 mfa2-D1 Chen et al., 1997
SM3102 MATa ste24D::LEU2 Progeny of SM3095 (Fujimura-Kamada, et al., 1997)
SM3103 MATa ste24D::LEU2 Fujimura-Kamada et al., 1997
SM3286 MATa ste24D::LEU2 [CEN URA3 MFA1] Fujimura-Kamada et al., 1997
SM3310 MATa [CEN URA3 MFA1] Transformant of SM1058 with pSM233
SM3375 MATa ste24D::LEU2 mfa1-D1 mfa2-D1 This study
SM3613 MATa rce1D::TRP1 This study
SM3614 MATa rce1D::TRP1 ste24D::LEU2 This study
SM3644 MATa rce1D::TRP1 [CEN URA3 MFA1] Transformant of SM3613 with pSM233
SM3650 MATa rce1D::TRP1 ste24D::LEU2 [CEN URA3] Transformant of SM3614 with pSM316
SM3651 MATa rce1D::TRP1 ste24D::LEU2 [CEN URA3 MFA1] Transformant of SM3614 with pSM233
SM3653 MATa rce1D::TRP1 ste24D::LEU2 [CEN URA3 STE24] Transformant of SM3614 with pSM1093
SM3683 MATa mfa1-D1 mfa2-D1 [CEN URA3 MFA1] Transformant of SM2331 with pSM1036
SM3684 MATa mfa1-D1 mfa2-D1 [CEN URA3 UBI-M] Transformant of SM2331 with pSM1366
SM3685 MATa mfa1-D1 mfa2-D1 [CEN URA3 UBI-P1] Transformant of SM2331 with pSM1368
SM3686 MATa mfa1-D1 mfa2-D1 [CEN URA3 UBI-P2] Transformant of SM2331 with pSM1369
SM3689 MATa rce1D::TRP1 mfa1-D1 mfa2-D1 This study
SM3691 MATa rce1D::TRP1 ste24D::LEU2 mfa1-D1 mfa2-D1 This study
SM3714 MATa ste24D::LEU2 mfa1-D1 mfa2-D1 [CEN URA3 MFA1] Transformant of SM3375 with pSM1036
SM3715 MATa ste24D::LEU2 mfa1-D1 mfa2-D1 [CEN URA3 UBI-P1] Transformant of SM3375 with pSM1368
SM3716 MATa ste24D::LEU2 mfa1-D1 mfa2-D1 [CEN URA3 UBI-P2] Transformant of SM3375 with pSM1369
SM3721 MATa rce1D::TRP1 mfa1-D1 mfa2-D1 [CEN URA3 UBI-P2] Transformant of SM3689 with pSM1369
SM3726 MATa rce1D::TRP1 ste24D::LEU2 mfa1-D1 mfa2-D1 [CEN URA3 UBI-P2] Transformant of SM3691 with pSM1369
SM3811 MATa rce1D::TRP1 This study
SM3812 MATa rce1D::TRP1 ste24D::LEU2 This study
SM3814 MATa rce1D::TRP1 ste24D::LEU2 [CEN URA3 Hs STE24] Transformant of SM3614 with pSM1468
*All strains are isogenic to SM1058 (trp1 leu1 ura3 his4 can1) with the exception of SM1067, SM1068, and SM1086.
Table II. Plasmids Used in This Study
Plasmid Genotype Reference
pConstructXIV CEN TRP1 UBI4-DHFR-HA Johnsson and Varshavsky, 1994
pGAL-HO CEN URA3 GAL-HO Herskowitz and Jensen, 1991
pHY01 YEp24 URA3 RCE1 Yashiroda et al., 1996
pRS316 CEN URA3 Sikorski and Hieter, 1989
pSM233 CEN URA3 MFA1 Chen et al., 1997b
pSM236 CEN URA3 MFA1; BamHI site inserted at codon 17 This study
pSM1036 CEN URA3 MFA1 This study
pSM1093 CEN URA3 STE24 Schmidt et al., 1998
pSM1284 Bluescript-RCE1 This study
pSM1285 rce1-D1::TRP1 (D116–315) This study
pSM1366 CEN URA3 UBI-M This study
pSM1368 CEN URA3 UBI-P1 This study
pSM1369 CEN URA3 UBI-P2 This study
pSM1468 CEN URA3 Hs STE24 This study
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The Biosynthetic Intermediate, P0*, Is
Metabolically Unstable
We have shown elsewhere that a defect in the carboxyl
methylation of a-factor correlates with the metabolic in-
stability of a-factor biosynthetic intermediates (Sapper-
stein et al., 1994). We compared the metabolic stability of
P0* and P1 generated by the double (ste24D rce1D) and
single (ste24D) mutants, respectively, by pulse-chase analy-
sis (Fig. 4 A). This experiment reveals that the methylated
P1 intermediate that accumulates in the ste24D mutant is
metabolically stable with a half-life greater than 60 min
(Fig. 4, A, lanes 7–9 and B). In contrast, the half-life of the
unmethylated P0* species present in the double ste24D
rce1D mutant is dramatically less (half-life of z9 min) (Fig.
4, A, lanes 10–12 and B). The biosynthetic profile and met-
abolic stability of the a-factor intermediates in the single
rce1D mutant does not appear to be significantly different
from that of the wild-type strain (Fig. 4 A, compare lanes
4–6 with 1–3).
Taken together, the experiments carried out in Figs. 3
and 4 indicate that although the gel mobility difference be-
tween P0* and P1 is small, they can be discriminated by a
large difference in their methylation level and metabolic
stability. P0* is unstable and unmethylated whereas P1 is
metabolically stable and methylated. The CAAX process-
ing of a-factor in the double mutant (ste24D rce1D) fails to
proceed beyond P0*, and thus is consistent with redundant
roles for Ste24p and Rce1p in COOH-terminal AAXing.
In contrast, the single ste24D mutant accumulates the sta-
ble, methylated P1 intermediate, indicating that COOH-
terminal AAXing can be carried out via Rce1p and that
Ste24p is needed to mediate the first NH2-terminal P1®P2
processing step in a-factor biogenesis.
Characterization of a-Factor Species Produced by 
Ubiquitin–a-Factor Fusions
Since Ste24p appears to have dual roles in a-factor matu-
ration involving both NH2- and COOH-terminal steps, we
Figure 3. The rce1D ste24D double mutant produces a novel
a-factor intermediate, P0*, that is unmethylated. (A) To examine
the a-factor biogenesis profile in wild-type and mutant strains,
cells were metabolically labeled with [35S]cysteine for 5 min. In-
tracellular (I) and extracellular (E) fractions were separated by
centrifugation and extracts were prepared as described in the Ma-
terials and Methods. Protein extracts were immunoprecipitated
with anti–a-factor antiserum no. 9-137, and subjected to SDS-
PAGE and PhosphorImager analysis. The previously character-
ized precursor species (P1, P2) and mature a-factor (M) are
shown. The band migrating slightly faster than M is the a-factor–
relabeled peptide (AFRP) and is discussed elsewhere (Chen et
al., 1997a). The asterisk (*) marks the new a-factor intermediate
P0* (refer to Fig. 1). (B) Carboxyl methylation levels of a-factor
were used as an indirect measure of AAXing activity in wild-type
and mutant strains. Cells were double-labeled with S-adenosyl-l-
[3H-methyl]methionine and [35S]cysteine for 6 min. Total cell ex-
tracts were prepared, immunoprecipitated with anti–a-factor
antiserum 9-137, and then subjected to SDS-PAGE and autorad-
iography. Bands representing each a-factor species (P0* or P1,
P2, and M) were excised from the dried gel. The degree of meth-
ylation for each band was measured by determining the [3H]/[35S]
cpm ratio. The relative methylation level was then calculated as a
fraction of the corresponding species from the wild-type strain
(100%). The ste14D strain is a control that lacks carboxyl methy-
lation activity. NP, no protein was detected by autoradiography.
The data are averaged from three independent experiments.
Strains are wild-type (SM3310), rce1D (SM3644), ste24D (SM3286)
rce1D ste24D (SM3651), and ste14D (SM1871).
Figure 4. P0* is metabolically unstable. (A) Pulse-chase analysis
of a-factor in wild-type and mutant strains. Cells were pulse la-
beled with [35S]cysteine for 5 min and chased with excess cold cys-
teine for the indicated times (min). Protein extracts were prepared,
immunoprecipitated with anti–a-factor antiserum 9-137, and then
analyzed by SDS-PAGE. Strains are wild-type (SM3310), rce1D
(SM3644), ste24D (SM3286), and rce1D ste24D (SM3651). (B)
Graph of a-factor precursor stability versus time. The amount of
the single a-factor species (either P1 or P0*) present at each time
point in the single (ste24D) and double (rce1D ste24D) mutants,
respectively, was quantitated by PhosphorImager analysis and
graphed as shown.The Journal of Cell Biology, Volume 142, 1998 642
sought a method to uncouple the two processing events.
This goal necessitated a way to produce mature active
a-factor independent of the normal NH2-terminal process-
ing steps. The expression of NH2-terminally truncated
MFA1 to directly generate the desired a-factor intermedi-
ates posed two problems: (a) translation requires an initia-
tor methionine and thus would yield abnormal versions of
the a-factor intermediates and (b) such MFA1 truncation
mutants were expressed poorly (Nouvet, F., and S.
Michaelis, unpublished data). Instead, we used a method
for expressing polypeptides that does not require the initi-
ator methionine (Bachmair et al., 1986). In this system, the
ubiquitin structural gene is fused to the gene of interest,
a-factor in our case. During translation, the ubiquitin moi-
ety is recognized by ubiquitin-specific proteases (Ubp),
which cleave precisely after the COOH-terminal residue of
ubiquitin (Tobias and Varshavsky, 1991; Baker et al., 1992),
and thus should yield the desired a-factor intermediates.
For this study, we made three ubiquitin–a-factor fusion
constructs, designated here as Ubi–a-factor fusions (Fig. 5
A). We fused the ubiquitin gene to the full-length MFA1
gene (Ubi-P1), and to the truncated MFA1 corresponding
either to the P2 intermediate (Ubi-P2) or to mature a-fac-
tor (Ubi-M). Ubi-P2 lacks the first seven residues of the
MFA1 precursor and Ubi-M lacks the entire NH2-terminal
extension. As shown in Fig. 5 B, Ubi-P1, Ubi-P2, and Ubi-M
directly generate the respective a-factor species that are
depicted diagrammatically in Fig. 5 A.
These Ubi–a-factor fusions show normal production of
mature exported a-factor, as determined by pulse-chase
metabolic labeling, immunoprecipitation, and SDS-PAGE.
As expected, the biogenesis profiles of Ubi-P1 and wild-
type MFA1 are indistinguishable from one another (Fig. 5
B, compare lanes 5–8 with lanes 1–4). The ubiquitin moi-
ety appears to be rapidly and effectively cleaved. Like-
wise, Ubi-P2 produces P2 directly, since it lacks the first
seven residues of the NH2-terminal extension. P2 is then
processed correctly to M, which is exported (Fig. 5 B, lanes
9–12). The Ubi-M construct directly yields the predicted
mature a-factor, which is exported normally (Fig. 5 B,
lanes 13–16). However, the intracellular mature species
derived from Ubi-M is metabolically unstable (Fig. 5 B,
lanes 13–16). By the a-factor spot dilution assay and by
mating assays carried out under stringent conditions, a
strain bearing Ubi-M produces somewhat reduced extra-
cellular a-factor activity compared with Ubi-P1 and Ubi-P2
Figure 5. Processing of Ubi–a-factor fusion proteins generate the expected a-factor species. (A) Ubi–a-factor fusions. To generate Ubi–
a-factor fusions, the sequence encoding a single copy of ubiquitin (Ubi) was fused precisely to the full-length a-factor gene MFA1 or to
truncated MFA1 corresponding to P2 or mature a-factor, yielding Ubi-P1, Ubi-P2, and Ubi-M, respectively. In all cases, the CAAX mo-
tif was retained in the fusion construct. The site of cleavage by the ubiquitin-specific proteases (Ubp) is indicated. The shading of re-
gions within a-factor correspond to that shown in Fig. 1. (B) Pulse-chase analysis of a-factor derived from wild-type MFA1 and Ubi–
a-factor fusions. The pulse-chase experiment was carried out as described in Fig. 4, except that the anti–a-factor antiserum 9-497 was
used. Chase times (min) are indicated. It should be noted that we do not detect the full-length forms of the Ubi–a-factor fusions, pre-
sumably because processing by the Ubps is cotranslational. We have observed the expected full-length Ubi–a-factor fusion upon intro-
duction of a COOH-terminal G76®V mutation in ubiquitin that abolishes the normal cut site for the Ubps (Nouvet, F. and S. Michaelis,
unpublished data). Strains bear deletions of the chromosomal a-factor genes (mfa1D mfa2D) and contain plasmids harboring wild-type
MFA1 (SM3683), Ubi-P1 (SM3685), Ubi-P2 (SM3686), or Ubi-M (SM3684). (C) a-Factor spot dilution assay. The amount of extracellu-
lar active a-factor produced by the Ubi–a-factor fusions was measured as described in the Fig. 2 legend. (D) Patch mating assay of Ubi–
a-factor fusions. For permissive and stringent mating conditions, the mating tester lawn is MATa (SM1068) resuspended in 100% YPD
and 1% YPD, respectively, as described in the Materials and Methods.Tam et al. Dual Roles for Ste24p in Yeast a-Factor Maturation 643
(Fig. 5, C and D). Presumably this is due to the lower
steady-state amount of exported a-factor, which in turn
possibly reflects inefficient methylation or perhaps a pro-
tective role normally played by the NH2-terminal exten-
sion (see Discussion). Since the Ubi-P1 and Ubi-P2 con-
structs produce mature a-factor that is stable and supports
mating (Fig. 5), we used these two constructs to study spe-
cific processing steps in a-factor biogenesis.
Ubi–a-Factor Fusions Provide Independent Evidence 
that Ste24p Plays a Critical Role in the NH2-terminal 
Processing of a-Factor
We used the Ubi–a-factor fusion constructs to confirm the
role of Ste24p in the first NH2-terminal cleavage step of
the a-factor precursor. To do so, we compared the process-
ing of Ubi-P1 versus Ubi-P2 in the ste24D mutant (Fig. 6).
As expected, MFA1 and Ubi-P1, which both possess the
Ste24p NH2-terminal cut site (P1®P2), are not properly
processed to mature a-factor in the ste24D mutant (Fig. 6,
lanes 4 and 5). In contrast, mature a-factor expressed from
the Ubi-P2 construct bypasses the requirement for STE24
in the ste24D mutant (Fig. 6, lane 6). The STE24 require-
ment in the production of mature a-factor by Ubi-P1, but
not by Ubi-P2, provides strong independent evidence for
the role of Ste24p in the first NH2-terminal cleavage step
of a-factor. Interestingly, these data also verify the obliga-
tory sequential order of the two NH2-terminal processing
steps of the a-factor precursor, reinforcing the notion that
the first seven residues of the NH2-terminal extension
must be removed before Axl1p can act in the second NH2-
terminal processing step.
Ubi-P2 Provides Independent Evidence for
the Overlapping Roles for Ste24p and Rce1p in
COOH-terminal AAXing of a-Factor
Since Ubi-P2 can bypass the need for STE24 in NH2-ter-
minal processing, we could study the involvement of
Ste24p in the COOH-terminal AAXing of a-factor in a
system where its NH2-terminal processing activity was not
required to generate mature a-factor. Thus, we were able
to probe the individual contributions of Ste24p and Rce1p
solely with respect to the AAXing of a-factor. We exam-
ined the amount of extracellular a-factor derived from
Ubi-P2 in wild-type and mutant strains by the spot halo as-
say. As shown in Fig. 7 A, compared with the wild-type,
the single mutants harboring Ubi-P2 show reduced but
equivalent levels of a-factor activity. This result with Ubi-P2
Figure 6. Ubi–a-factor fusions provide independent evidence
that Ste24p plays a critical role in NH2-terminal processing of
a-factor. (A) Schematic representation of wild-type a-factor, Ubi-
P1, and Ubi-P2, with the expected cleavages are shown. (B) Pro-
cessing of Ubi–a-factor fusions is compared in the wild-type and
ste24D mutant strains, as indicated. Radiolabeling and immuno-
precipitation with anti–a-factor antiserum 9-497 was carried out
as described in Fig. 3. Strains are wild-type and ste24D with
MFA1 (SM3683 and SM3714), Ubi-P1 (SM3685 and SM3715),
and Ubi-P2 (SM3686 and SM3716), respectively.
Figure 7. Ubi-P2 confirms overlapping roles for Ste24p and
Rce1p in COOH-terminal AAXing of a-factor; similar extracel-
lular  a-factor levels are produced from Ubi-P2 in the single
ste24D and rce1D mutants. (A) The a-factor spot dilution assay
was carried out as described in Fig. 2. The amount of a-factor de-
rived from Ubi-P2 is roughly equivalent when the endpoint dilu-
tions of the single rce1D and ste24D strains are compared. It is no-
table that the amount of a-factor derived from MFA1 differs
markedly in the single rce1D and ste24D mutants (compare with
Fig. 2). (B) Pulse labeling and immunoprecipitation of a-factor
expressed from Ubi-P2 in wild-type and mutant strains. Cells
were pulse labeled with [35S]cysteine for 2 min and the label was
chased with excess cold cysteine for the indicated times (min).
Immunoprecipitation of a-factor was carried out with anti–a-fac-
tor antiserum 9-497. Strains contain a plasmid harboring Ubi-P2 in
the wild-type (SM3686), rce1D (SM3721), ste24D (SM3716), or
rce1D ste24D (SM3726) backgrounds. (C) The diagram illustrates
the predicted structure of the Ubi-P2 and Ubi-P2* species.The Journal of Cell Biology, Volume 142, 1998 644
contrasts with our findings with MFA1 where the single
ste24D and rce1D mutants differ markedly in extracellular
a-factor levels (refer to Fig. 2 A). Apparently this differ-
ence is due to the additional role of Ste24p in NH2-termi-
nal processing of the full-length MFA1-encoded a-factor.
The use of Ubi-P2 thus allows us to dispense with the need
for the NH2-terminal processing activity and permits us to
conclude that Ste24p and Rce1p can play roughly equiva-
lent roles in contributing to the AAXing of a-factor. As
expected, the double mutant fails to produce any extracel-
lular a-factor from Ubi-P2, confirming the redundant roles
for Ste24p and Rce1p in a-factor AAXing.
We also examined the production of mature a-factor
from Ubi-P2 by pulse-chase analysis in wild-type and mu-
tant strains (Fig. 7 B). As predicted by the spot dilution
test, extracellular a-factor is generated by the single mu-
tants at a reduced level and is absent altogether for the
double mutant (Fig. 7 B). Notably, in the intracellular frac-
tions of all strains including the double mutant, we observe
the conversion of P2 to M (from Ubi-P2), indicating that
Axl1p processing is intact. A reasonable explanation for
the presence of intracellular but not extracellular a-factor
in the double mutant is that AAXing fails to occur and
consequently methylation is blocked. The lack of methyla-
tion would in turn prevent recognition by the Ste6p trans-
porter and therefore block export (Sapperstein et al.,
1994). To ascertain if AAXing is defective for Ubi-P2 in
the double mutant, we compared the methylation levels of
a-factor when the wild-type and mutant strains are ex-
pressing Ubi-P2 (Fig. 8). For the double mutant, we detect
no methylation for the slowest migrating band and thus
conclude that this band is P2*, not P2 (Fig. 7 C). This veri-
fies the overlapping roles of Ste24p and Rce1p in a-factor
AAXing. The single mutants bearing Ubi-P2 show slightly
different patterns of methylation from one another. The
methylation profile for Ubi-P2 in the ste24D mutant is sim-
ilar to that of the wild-type strain (Fig. 8), indicating that
Rce1p can mediate AAXing very efficiently. The rce1D
mutant strain also shows a methylation profile similar to
wild-type, but only 30 min after labeling. At the early time
point, the level of methylation is about half that of wild-
type (Fig. 8). Thus, the AAXing mediated by Ste24p in the
rce1D  mutant may be somewhat less efficient than that
mediated by Rce1p in the ste24D mutant. Nevertheless, ei-
ther Ste24p or Rce1p can mediate sufficient AAXing to
produce a substantial amount of steady-state mature a-factor.
The Human Ste24p Homologue Complements the
S. cerevisiae ste24D Mutants
CAAX processing is evolutionarily conserved. Multicellu-
lar organisms as well as yeast express and process CAAX
proteins, such as Ras. Of the trio of human CAAX-pro-
cessing enzymes, only the CAAX prenyl protease(s) has
not been cloned to date. Towards this end, we searched for
homologues of Ste24p in the database of expressed se-
quence tags and identified multiple ESTs with amino acid
similarity to S. cerevisiae Ste24p (Boyartchuk et al., 1997,
Fujimura-Kamada et al., 1997). Using a fragment from one
of these ESTs, N76181, we screened a human B cell cDNA
library and identified several positive clones encoding the
39 partial ORFs with sequence similarity to S. cerevisiae
Ste24p. The most complete clone encoded an ORF of 383
residues and contained the poly A tail. We obtained the
remaining 59 ORF sequence using the longest clone for 59
RACE PCR with a human fetal brain library.
The human clone, which we designate Hs STE24, en-
codes a protein of 475 amino acids with 36% identity and
51% similarity to the S. cerevisiae Ste24p (Fig. 9 A). Like
Ste24p of S. cerevisiae and S. pombe, Hs Ste24p has a char-
acteristic zinc metalloprotease motif (HEXXH: H, histi-
dine; E, glutamate; X, any amino acid), several cor-
responding transmembrane spans as predicted by
hydropathy analysis (Fig. 9 B), and regions I, II, and III
that are conserved among the homologues of this subfam-
ily of zinc metalloproteases (Fig. 9 A) (Fleischman et al.,
1995; Fujimura-Kamada et al., 1997; Kornitzer et al.,
1991). Interestingly, Hs STE24 has a short stretch of resi-
dues within region I that is not present in either yeast ho-
mologue (Fig. 9 A, dashed lines). Hs Ste24p does not pos-
sess a consensus dilysine ER localization signal at its
COOH terminus but does contain lysines at positions 23
and 26 from the COOH terminus (Fig. 9 A), which may
reflect a degenerate ER localization signal.
We expressed the human STE24 clone in S. cerevisiae
strains deleted for STE24 and RCE1 to examine whether
it can complement their mating defects. We find that Hs
STE24 partially corrects the mating defect of the double
ste24D rce1D mutant strain (Fig. 9 C) and fully comple-
ments the modest mating defect of the single ste24D mu-
tant under stringent mating conditions (data not shown).
These data suggest that Hs Ste24p can carry out both the
NH2-terminal processing and the COOH-terminal AAX-
ing steps in a-factor maturation.
Discussion
Ste24p Is Involved in Two Distinct
Proteolytic Maturation Steps of the a-Factor
Precursor: NH2- (P1®P2) and COOH-terminal 
(CAAX) Processing
The analysis of biosynthetic intermediates in a-factor bio-
genesis has facilitated the characterization of processing
activities required for several posttranslational modifica-
tions, including the CAAX farnesyltransferase (Ram1p/
Ram2p), the prenyl cysteine carboxyl methyltransferase
Figure 8. Relative methyla-
tion levels of Ubi-P2 in wild-
type and mutant strains.
Carboxyl methylation of
Ubi-P2–derived  a-factor was
used as an indirect measure
of AAXing activity in wild-
type and mutant strains, as
described in Fig. 3 B, except
that the radiolabel was chased
for 0 and 30 min and immunoprecipitation of a-factor was carried
out with anti–a-factor antiserum no. 9-497. The P2 or P2* bands
were excised from dried gel. The data are averaged from two in-
dependent experiments. Strains contain a plasmid harboring Ubi-P2
in the wild-type (SM3686), rce1D (SM3721), ste24D (SM3716), or
rce1D ste24D (SM3726) backgrounds.Tam et al. Dual Roles for Ste24p in Yeast a-Factor Maturation 645
(Ste14p), and the a-factor P2®M protease (Axl1p) (Hry-
cyna and Clarke, 1990; Schafer et al., 1990; He et al., 1991;
Adames et al., 1995). The present study focuses on the
most recently discovered a-factor processing component,
Ste24p, a transmembrane protease that has been previ-
ously assigned distinct, and seemingly disparate roles in
a-factor processing, by us and others. We showed that
Ste24p is required for the first NH2-terminal cleavage step
in a-factor biogenesis, the P1®P2 cleavage, by characteriz-
ing the a-factor intermediate that accumulates in a ste24
mutant (Fujimura-Kamada et al., 1997). In contrast, Bo-
yartchuk et al. (1997) provided evidence that Ste24p and
a dissimilar, but functionally redundant gene product
(Rce1p) are involved at a different step, COOH-terminal
CAAX processing of a-factor, using a biochemical assay.
Here we investigate and present compelling evidence for
the unifying hypothesis that Ste24p mediates dual steps in
the maturation of the a-factor precursor: COOH-terminal
CAAX processing and NH2-terminal (P1®P2) processing.
We show that Ste24p functionally overlaps with Rce1p
only for CAAX processing. Our evidence for the roles of
Ste24p and Rce1p in a-factor maturation is summarized
below.
We demonstrate that Ste24p and Rce1p are functionally
redundant for COOH-terminal CAAX processing of a-factor
by the characterization of biosynthetic intermediates gen-
erated in both the ste24 and rce1 single and double mu-
tants. A significant amount of AAXing occurs (indicated
Figure 9. The human homologue of Ste24p complements mating
defects of the yeast ste24D rce1D strain. (A) Amino acid align-
ment of Ste24p from S. cerevisiae, S. pombe, and H. sapiens. The
S. pombe homologue, called Sp Ste24p here, is known as YAN5
(GenBank/EMBL/DDBJ accession no. Q10071). Residues
shaded in black and gray, regions of identity and similarity, re-
spectively. The zinc metalloprotease motif (HEXXH) is marked
by asterisks (*). I, II, and III, conserved regions unique to mem-
bers of the Ste24p zinc metalloprotease subfamily. Dashed line (---)
within Region I, an additional region found solely within Hs
Ste24p (GenBank/EMBL/DDBJ accession no. AF064867). Solid
circles  (d), a degenerate COOH-terminal dilysine motif. (B)
Kyte and Doolittle hydropathy analysis of Sc Ste24p and Hs
Ste24p. (C) The human STE24 was tested for the ability to com-
plement the mating defect of the double rce1D ste24D mutant
strain. The patch mating assay was carried out as described in Fig.
2. The lawn of mating tester cells (SM1068) was resuspended in
5% YPD diluted in sterile water. Strains are ste24D rce1D con-
taining the vector only (SM3650), Sc STE24 (SM3653), or Hs
STE24 (SM3814). Hs STE24 has also been recently cloned inde-
pendently by H. Kumagai, K. Yanagisawa, and H. Komano (all
from National Institute for Longevity Sciences, Aichi, Japan)
(personal communication).The Journal of Cell Biology, Volume 142, 1998 646
by methylation) in each of the single mutants (ste24 or
rce1) but completely fails to occur in the double mutant
(ste24 rce1) (refer to Fig. 3 B) (see below for a discussion
of P0*). Since either STE24 or RCE1 is sufficient for
AAXing, and deletion of both genes results in a complete
defect in AAXing, we conclude that Ste24p and Rce1p
share redundant roles in a-factor AAXing and appear to
be the only CAAX proteases for a-factor in yeast.
A key finding here is the identification of the novel a-fac-
tor biosynthetic intermediate, P0*, in the double mutant
(ste24 rce1). P0* is an early a-factor intermediate that is in-
completely COOH terminally processed (prenylated but
not AAXed or methylated). P0* is formed before P1, from
which it shows only a subtle difference by gel mobility (re-
fer to Figs. 1 and 3). The lack of methylation and meta-
bolic instability of P0* distinguish it from P1, which is fully
methylated and metabolically stable. These methylation
differences between P1 and P0* stem from the absence or
presence of the AAX tripeptide, respectively, which must
be absent for the methyltransferase to act. The P0* species
of a-factor is transient, and thus is not readily apparent in a
wild-type strain. Presumably this is because each step of
CAAX processing occurs in rapid succession, resulting in
the fast conversion of P0* to P1; we can detect fully pro-
cessed a-factor (M) even after a short 5 min of pulse label-
ing. The accumulation of the unmethylated (and un-
AAXed) P0* in the double mutant (ste24 rce1) provides
the basis for our conclusion that Ste24p and Rce1p have re-
dundant roles for the COOH-terminal AAXing of a-factor.
A role for Ste24p in NH2-terminal processing of a-factor
was implicated by a block in P1®P2 processing that re-
sults in P1 accumulation (neither P2 nor M is formed) in
our initial study of the ste24 mutant (Fujimura-Kamada et al.,
1997). In the present study, we provide independent con-
firmation that Ste24p is in fact necessary for this step by
use of Ubi–a-factor fusions. The observation that produc-
tion of mature a-factor from a construct that lacks the
P1®P2 cut site (Ubi-P2) can bypass the Ste24p require-
ment for NH2-terminal processing is consistent with the
role of Ste24p in the first NH2-terminal processing step of
a-factor maturation (Fig. 6). Interestingly, although Ste24p
and Rce1p function redundantly for CAAX processing of
a-factor, Rce1p is unlikely to contribute to NH2-terminal
processing, based on the finding that P1 fails to be con-
verted to P2 in the ste24 mutant where Rce1p is present
(refer to Fig. 3 A).
As described above, Ste24p has dual roles in a-factor
processing and functionally overlaps with Rce1p in one of
these steps. This predicts that Rce1p should be dispens-
able for a-factor processing. Indeed, we observe that in the
rce1 single mutant, the a-factor biogenesis profile is similar
to wild-type; P2 and M are generated at similar rates in the
rce1 mutant as in a wild-type strain and export of M is also
indistinguishable in these two strains (refer to Fig. 3 A and
Fig. 2).
Having established here that Ste24p participates in two
distinct proteolytic processing steps for a-factor, we can
explain the previous discrepant findings for the role of
Ste24p (Boyartchuk et al., 1997; Fujimura-Kamada et al.,
1997). These were due to (a) the use of two different as-
says and (b) the complexity arising from the situation that
one protein, Ste24p, carries out two functions and that two
proteins, Rce1p and Ste24p, mediate a common step. Our
combined approach of examining the NH2- and COOH-
terminal processing steps of a-factor in strains deleted for
STE24 and RCE1 has now resolved this issue.
a-Factor Production and Mating in ste24 and rce1 
Single and Double Mutants
In light of our current view of dual functions for Ste24p
(COOH-terminal AAXing and NH2-terminal cleavage)
and a single function for Rce1p (COOH-terminal AAX-
ing), we can reevaluate the mature a-factor production
and mating phenotypes of the ste24 and rce1 single and
double mutants (Fig. 2). The double mutant (ste24 rce1) is
completely sterile because it can carry out neither COOH-
nor NH2-terminal processing, and thus does not produce
any mature a-factor. As expected, the rce1 mutant has a
wild-type mating efficiency because Ste24p mediates both
NH2- and COOH-terminal processing of a-factor in this
strain. In contrast, the ste24 mutant has a dramatically de-
creased mating efficiency (5% of wild-type) (Fujimura-
Kamada et al., 1997), that is due solely to a block in NH2-
terminal processing, since COOH-terminal AAXing can
be carried out by Rce1p in the ste24 mutant.
The residual mating exhibited by the ste24 mutant is sig-
nificant since it reflects a low level of mature a-factor pro-
duction. What gene product is responsible for the residual
a-factor processing in the ste24 mutant? An unknown en-
zyme, or possibly even Rce1p, could mediate a very low
level of P1®P2 cleavage. Alternatively, the P1®P2 pro-
cessing step might be bypassed at a low level by a one-step
removal of the entire NH2-terminal extension from P1. A
candidate for this latter possibility is Axl1p, whose normal
role is to mediate the second NH2-terminal (P2®M) cleav-
age step (between N21 and Y22) in a-factor processing.
Axl1p may be able to generate mature a-factor directly from
P1 somewhat inefficiently (P1®M cleavage). We favor the
second hypothesis because overexpression of AXL1 can
significantly suppress the ste24 mating defect (Fujimura-
Kamada, K., and S. Michaelis, unpublished results).
Overlapping Roles for Ste24p and Rce1p
As discussed above, the SDS-PAGE and phenotypic anal-
yses of the rce1 and ste24 single and double mutants indi-
cate that either Ste24p or Rce1p is sufficient for the
COOH-terminal AAXing of a-factor. Using the Ubi-P2
construct to circumvent the Ste24p requirement for NH2-
terminal processing, we could investigate the individual
contributions of Ste24p and Rce1p solely to the COOH-
terminal AAXing of a-factor. Based upon a-factor spot di-
lution assays and SDS-PAGE analysis (refer to Fig. 7), we
concluded that Ste24p and Rce1p each can carry out a sub-
stantial amount of the AAXing of a-factor, since the single
mutants produced approximately equivalent amounts of
the bioactive mature species. Although the levels of P2
methylation in the single mutants expressing Ubi-P2 are
indistinguishable from one another at a later time point, at
an early time point their methylation levels differ by
z50% (i.e., a twofold lower level of methylation in the
rce1 versus the ste24 strains for P2 [refer to Fig. 8]). This is
consistent with findings for the somewhat asymmetric
roles of Ste24p and Rce1p in a-factor AAXing (35 versusTam et al. Dual Roles for Ste24p in Yeast a-Factor Maturation 647
60%, respectively) using an in vitro AAXing assay with a
synthetic peptide substrate and membrane extracts from
mutant strains (Boyartchuk et al., 1997).
It is rather surprising that Ste24p and Rce1p function re-
dundantly in the CAAX processing of a-factor, since they
are neither homologues nor do they share common consen-
sus sequences. Whereas Ste24p possesses the HEXXH zinc
metalloprotease motif, Rce1p lacks any known protease
motifs. The sole resemblance between Ste24p and Rce1p is
that both are extremely hydrophobic with several predicted
membrane spans. This situation contrasts with another re-
dundant pair of a-factor processing components, Axl1p and
Ste23p, that are structurally similar to each other and con-
tain the same protease motif (Adames et al., 1995). Both
Axl1p and Ste23p can mediate the final cleavage step
(P2®M) in a-factor maturation, accounting for .90% and
,10% of processing, respectively (Adames et al., 1995).
Given the dissimilarity of Ste24p and Rce1p and that
their roles do not overlap completely, it is possible that
one (or both) of these proteins acts indirectly in a-factor
maturation. Ste24p and/or Rce1p may regulate another
protease(s) that cleaves a-factor. Because Rce1p lacks any
currently known protease motifs, it may either be a cofac-
tor involved in AAXing or it may represent a novel pro-
tease. The development of an in vitro assay with purified
Ste24p (or Rce1p) and its substrate will resolve this issue.
Since both candidate proteases, Ste24p and Rce1p, as well
as the potential substrate, prenylated a-factor, are quite
hydrophobic and likely membrane bound, the purification
and assay development will be challenging.
STE24 likely encodes a protease, however, because the
conserved protease motif of Ste24p is necessary to comple-
ment the mating and a-factor production defects of a ste24
mutant (Boyartchuk et al., 1997, Fujimura-Kamada et al.,
1997). Furthermore, mutations in the HEXXH motif are
sufficient to abolish AAXing as well as NH2-terminal pro-
cessing (data not shown). Aside from the Ste24p subfamily
of unusually hydrophobic zinc metalloproteases (Fujimura-
Kamada et al., 1997), only one other subclass of HEXXH
multispanning membrane proteases is known, the unre-
lated S2P protease involved in cholesterol homeostasis
(Rawson et al., 1997). Both the S2P protease and its sub-
strate are very hydrophobic (Rawson et al., 1997). S2P re-
leases the sterol regulatory element binding protein tran-
scription factor by cleaving within a transmembrane span
(Hua et al., 1996; Sakai et al., 1996). It will be interesting to
see how such a hydrophobic protease recognizes and pro-
cesses its similarly hydrophobic substrate and whether
Ste24p and S2P use analogous processing mechanisms.
If Ste24p directly cleaves a-factor, then how does Ste24p
cut its substrate at two distinct sites? The COOH-terminal
AAXing site (between residues C32, which is prenylated,
and V33) bears no resemblance to the NH2-terminal
P1®P2 processing site (between residues T7 and A8).
One explanation is that the prenyl cysteine serves as a
landmark or recognition site for recruitment of Ste24p and
that cleavage occurs at certain nearby sites. Alternatively,
Ste24p could have broad substrate specificity, like the sig-
nal peptidases that recognize hydrophobic residues (for
review see Dalbey et al., 1997). Ferreting out the rules for
Ste24p cleavage will require assaying a large number of
defined substrates.
Since Ste24p and Rce1p are not homologues but do
function redundantly in a-factor processing, it is reason-
able to postulate that each enzyme recognizes subsets of
overlapping substrates. Various CAAX-containing pro-
teins possess different CAAX sequences. Specific CAAX
sequences can direct farnesylation, geranylgeranylation,
or even both (Moores et al., 1991; Trueblood et al., 1993,
1997; Caplin et al., 1994, 1998), which could also provide
another level of substrate discrimination for Ste24p and
Rce1p. Although Ste24p and Rce1p mediate processing of
the a-factor CAAX box, each is also likely to promote
AAXing of other yeast CAAX proteins, such as Ras or
the g subunit (Ste18p) of the heterotrimeric G protein that
transduces the pheromone response. For example, it has
been suggested that Rce1p is involved in AAXing of
Ras2p, whereas Ste24p is not (Boyartchuk et al., 1997;
Schmidt et al., 1998). The function of another CAAX pro-
tein, Ste18p, does not require Ste24p and Rce1p since the
MATa ste24 rce1 mutant does not have a mating defect
(Fig. 2 B). This suggests that (a) Ste18p does not require
AAXing by Ste24p and Rce1p for its function, (b) AAX-
ing is not necessary for Ste18p function, or (c) another un-
identified CAAX protease processes Ste18p. The sub-
strate specificities of Ste24p and Rce1p remain to be
elucidated.
Insight into the Role of the NH2-terminal Extension of 
a-Factor by Ubi–a-Factor Fusions
In addition to reaffirming the role of Ste24p in NH2-termi-
nal processing, the Ubi–a-factor fusions provided a
method to verify the order of a-factor processing events
and also to examine the role of the NH2-terminal exten-
sion in the production and export of mature a-factor. First,
the NH2-terminal extension must be removed in two suc-
cessive steps for production of mature a-factor. This se-
quence of events is based on the finding that the second
NH2-terminal processing step by Axl1p can proceed effi-
ciently only after completion of the first NH2-terminal
cleavage, either via Ste24p or as encoded by Ubi-P2. The
P1®P2 cut could expose the substrate recognition site for
Axl1p. Second, since the NH2-terminal extension is ulti-
mately removed from a-factor before its export, a reason-
able hypothesis is that the NH2-terminal extension could
play a transient role, such as targeting a-factor to its trans-
porter, Ste6p. However, our results with Ubi-M suggest
that this is not the case because Ubi-M, which lacks the
NH2-terminal extension, can still produce mature a-factor
that is properly exported (refer to Fig. 5 B). Instead, the
major difference between mature a-factor generated con-
ventionally from MFA1 or unconventionally from Ubi-M
is that the latter is highly metabolically unstable. An inter-
esting possibility is that the NH2-terminal extension plays
a role in protecting a-factor from degradation. A candi-
date for a degradation pathway is the N-end rule pathway
since the first residue (tyrosine) of mature a-factor is a de-
stabilizing residue. Another possibility is that the NH2-ter-
minal extension acts as a chaperone to stabilize mature
a-factor. Alternatively, the mature species derived from
Ubi-M may not be methylated as efficiently as wild-type
a-factor, and thus could be degraded by the same machin-
ery that degrades P0*.The Journal of Cell Biology, Volume 142, 1998 648
Model for Intracellular a-Factor Processing
and Trafficking
Most secreted molecules, such as the other S. cerevisiae
mating pheromone a-factor, undergo posttranslational pro-
cessing in the lumenal compartments of the secretory
pathway. In contrast, a-factor and other CAAX proteins
are thought to be COOH terminally processed in the cyto-
sol or on the cytosolic face of membranes. For example, it
has been suggested that most of unprocessed Ras2p accu-
mulates on intracellular membranes in yeast strains de-
leted for the CAAX proteases (ste24 rce1) (Boyartchuk et al.,
1997). We have sought elsewhere to define the intracellu-
lar site where a-factor CAAX processing and NH2-termi-
nal processing take place (Schmidt et al., manuscript sub-
mitted for publication). In those studies, we demonstrated
by subcellular fractionation and indirect immunofluores-
cence that the CAAX proteases (Ste24p and Rce1p) and
the methyltransferase (Ste14p) are localized to the mem-
brane of ER, presumably with their active sites facing the
cytosol (Romano et al., 1998, Schmidt et al., manuscript
submitted for publication). Those findings, together with
the results presented here that show dual roles for Ste24p,
lead to our current view of the intracellular trafficking and
processing of a-factor (refer to Fig. 1). The newly synthe-
sized a-factor precursor (P0) is prenylated by the cytosolic
Ram1p/Ram2p complex, permitting its association with the
ER membrane. At the cytosolic face of the ER membrane,
prenylated  a-factor (P0*) completes COOH-terminal
CAAX processing, including AAXing by Rce1p or Ste24p,
followed by carboxyl methylation by Ste14p to form P1.
Next, the first NH2-terminal cleavage step is mediated by
Ste24p to yield P2. P2 is subsequently shuttled to another
compartment where Axl1p (or Ste23p) (Schmidt, W.K., and
S. Michaelis, unpublished data) performs the final cleavage
step to generate M, which is then exported by Ste6p.
This model raises two intriguing issues. First, since
Ste24p, Rce1p, and Ste14p are localized to the same intra-
cellular membrane and act sequentially in CAAX process-
ing, these three components could form a complex, a notion
that we are presently investigating. Second, how does a pre-
nylated protein, and a-factor in particular, traffic from the
ER to its final destination (the plasma membrane)? We
propose that a-factor could diffuse through the cytosol, use
a carrier, or hitchhike on the outside of vesicles using the
classical secretory pathway (Schmidt et al. 1998).
Human Ste24p Functions in Yeast
The COOH-terminal CAAX protein motif and its pro-
cessing enzymes are conserved evolutionarily among eu-
karyotes. Here we report the cloning of the first mamma-
lian CAAX prenyl protease, human (Hs) STE24. We have
shown elsewhere that S. cerevisiae (Sc) STE24 defines a
novel subfamily of zinc metalloproteases containing ho-
mologues from bacteria (E. coli, H. influenza) and other
fungi (S. pombe) (Fujimura-Kamada et al., 1997). Addi-
tionally, ESTs that are similar to STE24 exist in many mul-
ticellular organisms (A. thaliana, C. elegans, D. melano-
gaster, M. musculus, H. sapiens). Members of the Ste24p
subfamily are characterized by multiple membrane spans,
a zinc metalloprotease motif (HEXXH), several highly
conserved regions designated I, II, and III, and a COOH-
terminal dilysine motif potentially involved in ER retrieval.
Hs Ste24p and Sc Ste24p are 36% identical and 51% simi-
lar; Hs Ste24p shares the common features of this subfam-
ily. However, instead of the canonical dilysine motif for ER
retrieval (lysines at positions 23 and 24, or 23 and 25
from the COOH terminus), Hs Ste24p possesses what may
be a degenerate dilysine motif (lysines at positions 23 and
26). It will be interesting to determine if human Ste24p,
like its S. cerevisiae counterpart, is localized to the ER
membrane. We expect that this will be the case, since an-
other CAAX processing component (Ste14p methyltrans-
ferase) localizes to the ER membrane in yeast and mam-
malian cells (Dai et al., 1998; Romano et al., 1998).
We show by complementation that Hs Ste24p can function
in yeast (Fig. 9 C). Notably, Hs Ste24p complements the mat-
ing defect of the double mutant (ste24 rce1), suggesting that it
is capable of mediating not only COOH-terminal AAXing,
but also NH2-terminal processing of a-factor (Fig. 9 C). What
is the physiological substrate for Hs Ste24p; is there a human
homologue for a-factor that undergoes similar processing
steps? Clearly, no such human substrate has been discovered
to date. A potential substrate is the prelamin A precursor,
which undergoes a series of maturation steps that includes
COOH-terminal CAAX processing, followed by a subse-
quent proteolytic cleavage located 14 residues NH2-terminal
to the prenyl cysteine (Weber et al., 1989). This latter cleav-
age may be analogous to the NH2-terminal processing of
a-factor, which occurs at sites that are 26 and 12 residues
away from the prenyl cysteine (Chen et al., 1997b). The
endoprotease that processes the prelamin A precursor has
yet to be cloned, although an enzymatic activity has been
detected in nuclear extracts (Kilic et al., 1997). In addition to
a possible role in NH2-terminal proteolytic cleavage similar
to the P1®P2 cut of the a-factor precursor, Hs Ste24p is also
likely to be involved in the processing of multiple CAAX
proteins found in diverse human cell types. ESTs of Hs
STE24 have been identified in cDNA libraries derived from
a variety of tissues (fetal brain, bone, prostate, fetal lung, pan-
creas tumor, human tonsillar cells enriched for germinal cen-
ter B cells, retina, and heart) indicating a wide expression
pattern. We anticipate that future studies will reveal the
mammalian substrates of Ste24p, some of which may use a
processing pathway similar to that of yeast a-factor.
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